SEARCH

SEARCH BY CITATION

References

  • 1
    Stenius K., Babor T. F. The alcohol industry and public interest science. Addiction 2010: 105: 1918.
  • 2
    Bond L., Daube M., Chikritzhs T. Access to confidential alcohol industry documents: from ‘Big Tobacco’ to ‘Big Booze’. Australasian Medical Journal 2009; 1: 126. doi 10.4066/AMJ.2009.43
  • 3
    De La Figuera M. Coffee consumption and hepatobiliary system. Med Clin 2009; 10: 15.
  • 4
    Franco R. Coffee and cancer. Med Clin 2009; 10: 57.
  • 5
    Riobó P., González E. Coffee and diabetes mellitus. Med Clin 2009; 10: 813.
  • 6
    Ferré S. Caffeine and Parkinson's disease. Med Clin 2009; 10: 149.
  • 7
    Palacios N., Iglesias Gutiérrez E., Úbeda Martín N. Efectos de la cafeina en el rendimiento deportivo [Effects of caffeine on sports performance. Med Clin 2009; 10: 204.
  • 8
    Cunha R. A. Caffeine, adenosine receptors, memory and Alzheimer's disease. Med Clin 2009; 10: 2530.
  • 9
    Miller P., Kypri K. Why we will not accept funding from Drinkwise. Drug Alcohol Rev 2009; 28: 3246.
  • 10
    Lesser L. I., Ebbeling C. B., Goozner M., Wypij D., Ludwig D. S. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 2007; 4: e5. doi: 10: 1371/journal.pmed.0040005.
  • 11
    Mason B. J., Goodman A. M., Chabac S., Lehert P. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res 2006; 40: 38393.